TrialInternational journal of hematology2023
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia.
Naoyuki Miyagawa et al.PubMed ↗Publisher ↗
No numbers read from the abstract.